609 related articles for article (PubMed ID: 34696483)
1. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
[TBL] [Abstract][Full Text] [Related]
2. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
[TBL] [Abstract][Full Text] [Related]
3. Improved detection of early acute, late acute, and occult Hepatitis B infections by an increased sensitivity HBsAg assay.
Kuhns MC; Holzmayer V; McNamara AL; Sickinger E; Schultess J; Cloherty GA
J Clin Virol; 2019 Sep; 118():41-45. PubMed ID: 31442662
[TBL] [Abstract][Full Text] [Related]
4. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
[TBL] [Abstract][Full Text] [Related]
6. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
8. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
9. Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in Brazil.
Almeida RW; Mello FCDA; Menegoy IV; Santo MPDE; Ginuíno CF; Sousa PSF; Villar LM; Lampe E; Lewis-Ximenez LL
Mem Inst Oswaldo Cruz; 2017 Jul; 112(7):485-491. PubMed ID: 28591309
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
Stolz M; Tinguely C; Fontana S; Niederhauser C
Transfusion; 2014 Nov; 54(11):2961-7. PubMed ID: 24805974
[TBL] [Abstract][Full Text] [Related]
11. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
Kuhns MC; Busch MP
Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus markers in anti-HBc only positive individuals.
Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
[TBL] [Abstract][Full Text] [Related]
13. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
Martin LA; Stramer SL; Kuhns MC; Schlauder GG
Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of individual donor nucleic acid testing (NAT) for the detection of hepatitis B infection by studying diluted NAT yield samples.
Arora S; Doda V; Kirtania T
Blood Transfus; 2015 Apr; 13(2):227-32. PubMed ID: 25369612
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
[TBL] [Abstract][Full Text] [Related]
18. Detection of hepatitis B virus infection in German blood donors 2008-2015.
Scheiblauer H; Heiden M; Funk M; Oberle D; Kreß J; Jork C; Chudy M
Vox Sang; 2020 Apr; 115(3):152-161. PubMed ID: 32023664
[TBL] [Abstract][Full Text] [Related]
19. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
[TBL] [Abstract][Full Text] [Related]
20. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
Dodd RY; Nguyen ML; Krysztof DE; Notari EP; Stramer SL
Transfusion; 2018 Sep; 58(9):2166-2170. PubMed ID: 30144082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
